To study the primary structure and regulation of human cholinesterases, oligodeoxynucleotide probes were prepared according to a consensus peptide sequence present in the active site of both human serum pseudocholinesterase (BtChoEase; EC 3.1
Two types of cholinesterases are capable of rapidly hydrolyzing the neurotransmitter acetylcholine in humans. These are the "true" acetylcholinesterase (AcChoEase; acetylcholine acetylhydrolase, EC 3.1.1.7) and the "pseudo-" or butyrylcholinesterase (BtChoEase; acylcholine acylhydrolase, EC 3.1.1.8), distinguished by their substrate specificity and sensitivity to selective inhibitors (1) . Both enzymes are rare ubiquitous proteins that exist in parallel arrays of multiple molecular forms with similar kinetic properties. The molecular forms differ in the number of catalytic subunits (2) , in their level of hydrophobicity (3) and mode of glycosylation (4) , and in their cellular and subcellular localization (1) . In the human brain (5), AcChoEase is the major species, accompanied by minor BtChoEase activities. In the blood, amphipathic AcChoEase dimers are bound to erythrocyte membranes by non-amino acid components (6) , whereas soluble BtChoEase tetramers, presumed to be produced in the liver, are present in the serum (7) .
Polyclonal and monoclonal antibodies raised against purified human erythrocyte AcChoEase were shown to crossreact with AcChoEase from other tissues and species (8) (9) (10) but not with human BtChoEase (10) , whereas antibodies against whole human serum were found to precipitate active BtChoEase (11) . In addition, peptide sequencing revealed considerable homology between the active site peptides of human serum BtChoEase (7) and the "true" AcChoEase from the electric organ of Torpedo californica (12) . Altogether, these observations suggest that various cholinesterases share common domains but may also contain regions specific to particular species and forms. Oocyte microinjection experiments indicate that the polymorphism of human cholinesterases extends to the level of mRNA (13) , and individuals with genetically inherited BtChoEase deficiencies display normal AcChoEase activities (14) , suggesting that in humans distinct DNA sequences are involved in the synthesis of AcChoEase and BtChoEase. These could code either for different AcChoEase and BtChoEase polypeptides or for other proteins, required for various post-translational processing events of a single type of cholinesterase precursor. To directly approach this issue by revealing the primary sequence of human cholinesterases and the regulation of their expression, we searched for cholinesterase cDNA clones by using oligodeoxynucleotide probes prepared according to a consensus peptide sequence present in the active site of both human BtChoEase (7) and Torpedo AcChoEase (12) .
METHODS
Poly(A)+ RNA was extracted from fetal human brain and liver (18 weeks gestation) and was tested for the presence of cholinesterase mRNA by oocyte microinjection followed by cholinesterase bioassay (13) . cDNA libraries (constructed by A. Ullrich of Genentech) were prepared from these RNA preparations and were inserted into the EcoRI site of XgtlO, using a polylinker containing restriction sites for EcoRI, Xho I, Sal I, and Sst I. The fetal brain XgtlO library (1.6 x 106 plaque-forming units) was plated out, and nitrocellulose filter copies were prepared and screened with two overlapping oligodeoxynucleotide probes (15) . Each probe was designed to complement the predicted mRNA sequence as follows.
in which N equals A, C, G, or T and only one or the other of the two triplets in parentheses is present, a 17-mer with a 256-fold degeneracy that represents the consensus peptide sequence, Phe-Gly-Glu-Ser-Ala-Gly, present in human serum BtChoEase (7) and in "true" AcChoEase from Torpedo electric organ (12) . Probe OPSYNO, d[3'-AAdCCICTt(TCd, A AGI)CGICCICGICGI(TCc,AGI)CA1, a 29-mer with a 36-fold degeneracy that codes for the peptide Phe-Gly-Glu-Ser-AlaGly-Ala-Ala-Ser-Val found in human serum BtChoEase (7) and that differs from the parallel peptide of Torpedo AcChoEase by one amino acid (no. 7 in this peptide, Gly in Torpedo) (12 Proc. Natl. Acad. Sci. USA 84 (1987) possible by insertion of deoxyinosine in positions where codon ambiguity permits all four nucleotides (16) . Both probes were manually synthesized, using phosphoramidite chemistry (17) . Oligodeoxynucleotides were 5'-end-labeled with [y-32P]ATP (5000 Ci/mmol, Amersham; 1 Ci = 37 GBq) and polynucleotide kinase (New England Nuclear). Hybridization was as described (15) , followed in the third screen by 3 M tetraniethylammonium chloride washes at 53°C (18) . Under these conditions, only a single clone in the fetal brain library, designated FBChE12, gave a significant hybridization signal with both probes. The FBChE12 DNA was purified and 32P-labeled by nick-translation and employed as a probe to screen the fetal brain and liver libraries. Hybridization and washing were performed as previously described (15 (Fig. 2) , suggesting that both cDNAs were derived from similar mRNA transcripts. When the amino acids predicted from the FBChE12 and the FL39 sequence are aligned with the available peptide sequences published for human BtChoEase, the entire coding region for the mature enzyme is defined, starting at residue 1 (nucleotide 160), which corresponds to the N-terminal peptide, and ending at residue 574 (nucleotide 1881), which is the last amino acid residue in the C-terminal tryptic peptide of BtChoEase as determined from amino acid sequencing (7) . This sequence also includes the active site tryptic peptide of human BtChoEase, which contains a serine residue that can be labeled by diisopropyl fluorophosphate (7) (Fig. 2, circled) . The N-terminal peptide inferred from the FBChE12 and the FL39 sequences is similar to the BtChoEase peptide, except that in our sequence residue 12 is Lys, as in the N-terminal peptide of Torpedo AcChoEase (12) , whereas the corresponding residue of human BtChoEase found by amino acid sequencing is Gly (7). The general amino acid composition of the protein encoded by FL39 was very similar to that reported for human BtChoEase (7), with several exceptions, for example, BtChoEase has 7 more proline residues and 6 fewer tryptophan residues; in contrast, the amino acid composition of the FL39-encoded protein clearly differed from the parallel composition derived for erythrocyte AcChoEase (25) . In addition, the N terminus of the cholinesterase encoded by FBChE12 and FL39 differs from the peptide reported for erythrocyte AcChoEase (26) . All together, this strongly suggests that both FBChE12 and FL39 code for BtChoEase.
The region upstream of the BtChoEase N-terminal residue (nucleotides 88-147) in FBChE12 codes for 20 amino acids characteristic of leader peptides of membrane-associated and exported protein precursors (27) (19) . Sequential series of overlapping clones were produced by generating deletions of various sizes from both ends of the inserts through the 3'-to-5' exonuclease activity of T4 DNA polymerase (20) . DNA sequencing of the resulting M13-FBChEi2 and M13-FL39 recombinants was done by the dideoxynucleoside procedure (21) , using the universal 17- (24) , are also circled. Cys residues are enclosed in hexagons. The FL39 sequence also includes a long 3' untranslated region, ending with a polyadenylylation site and a poly(A) tail.
upstream, the cDNA sequence consists of a fully open reading frame without stop codons, and it includes a putative ribosome binding site (Fig. 2) . The coding region in the DNA (Fig. 3A) and inferred amino acid sequence (Fig. 3B) 5 conservative matches for amino acid residues. Nucleotides are numbered in the 5'-to-3' direction and amino acids in the Nto-C direction for both cDNAs. The homologies start from around nucleotide 110 in FBChE12, a region that matches the beginning of the Torpedo cDNA clone. A/~~~~~~~~~~ level of conservation was found at the amino acid level (Fig.  3B) than at the nucleotide level (Fig. 3A) .
The cDNA inserts were 32P-labeled and hybridized with human RNA and DNA. In low-stringency RNA blots loaded with 10 ,g of poly(A)+ RNA per lane, 32P-labeled FBChE12 interacted with a single 2.5-kb band of RNA, of a similar size as the FL39 clone. This mRNA was present in fetal brain and liver, but not in the cholinesterase-deficient human epidermoid carcinoma (HEp), which does not express any type of cholinesterase activity (ref. 13, Fig. 4A ).
The levels of the mRNAs coding for particular types of cholinesterase in fetal brain and liver were analyzed in parallel by mRNA lated to yield their catalytically active enzyme products (13) . Considerable production of iso-OMPA-insensitive AcChoEase was observed in oocytes injected with either fetal brain or liver RNA but not with HEp RNA. In contrast, only liver mRNA was capable of producing significant levels of BW284C51-insensitive BtChoEase (Fig. 4A) . Thus, the pattern revealed in the RNA blot hybridization (Fig. 4B) is compatible with the levels of both species of cholinesterase mRNA together, but not with BtChoEase mRNA alone.
A DNA blot hybridized with [32P]FBChE12 is presented in Fig. 5 . The 32P-labeled cholinesterase cDNA insert hybridized with two distinct human DNA fragments derived by digestion with EcoRI, 4.7 and 2.5 kb in length. When FL39 was used as a probe, an additional band of ca. 10 kb was revealed (not shown). Taking into account the existence of the unique EcoRI site in the original FBChE12 and FL39 cDNA clones (Fig. 1) , this indicates the presence of at least one intervening sequence within the gene. Comparison of the signal intensity observed with 20 ,g of genomic DNA to that detected with 1.0 ng of AgtlO-FBChE12 (Fig. 5) (13) by extraction in guanidine thiocyanate followed by two rounds of oligo(dT)-cellulose chromatography (15) . Fifty nanograms of each poly(A)+ RNA was injected into each of 10 oocytes for a 20-hr incubation at 17°C (13) , and the resulting cholinesterase activity was determined by measuring the rate of hydrolysis of [3H]acetylcholine (5, 13) in oocyte extracts and incubation medium, in the presence of 0.1 mM tetraisopropyl pyrophosphoramide (iso-OMPA) or 10 ,uM 1,5-bis[4-(allyldimethylammonium)phenyl]pentan-3-one dibromide (BW284C51) so as to selectively block the activities of BtChoEase and of AcChoEase, respectively (13, 14) . The 
DISCUSSION
The polypeptide inferred by the nucleotide sequences of FBChE12 and FL39 shares amino acid sequences with human BtChoEase (7), which is, indeed, present in the fetal human brain (5) and liver (14) . In addition, the FBChE12 and FL39 fragments appear to be derived from a relatively small region in the human genome. Under low-stringency conditions, they hybridized with equal efficiency with mRNA from preparations rich in either fetal AcChoEase mRNA or BtChoEase mRNA. The most straightforward explanation for these findings is that these clones were reverse-transcribed from BtChoEase mRNA.
According to these findings, the cholinesterase(s) encoded by the FBChE12 and the FL39 clones are produced from one or a few genes but not from a multigene family. Differential splicing or alternative transcription of a single gene, or independent expression of a few related genes, can direct the synthesis of several highly homologous cholinesterase mRNAs, differing in limited domains [e.g., N terminus (26) ]. This is compatible with the finding of intervening sequences within this human gene.
Note Added in Proof. While this manuscript was being processed, we received a manuscript describing the complete amino acid sequence of human serum cholinesterase as determined by peptide sequencing by Lockridge and co-workers (32) . The complete identity of the two sequences as derived by DNA and by peptide sequencing proves beyond doubt that the isolated cDNA codes for human BtChoEase, and we thank Dr. Lockridge for providing us with this information at the galley proof stage.
